Adjuvant combined-modality therapy for stage IIIC endometrioid and non-endometrioid endometrial cancer.

Affiliation

Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA. Electronic address: [Email]

Abstract

To identify the optimal adjuvant treatment regimen for patients with endometrioid and non-endometrioid node-positive endometrial cancer.

Keywords

Adjuvant therapy,Endometrioid,FIGO stage IIIC endometrial cancer,Node-positive endometrial cancer,Non-endometrioid,